A 62-year-old woman with AF (CHA₂DS₂‑VASc=5) on apixaban develops CDI. Which CDI regimen minimizes drug interactions and recurrence?...

Question

A 62-year-old woman with AF (CHA₂DS₂‑VASc=5) on apixaban develops CDI. Which CDI regimen minimizes drug interactions and recurrence?

Accepted Answer

Fidaxomicin 200 mg BID × 10 days

Answer

Metronidazole 500 mg TID × 10 days

Answer

Vancomycin taper/pulse first-line

Answer

Stop anticoagulation during CDI therapy

Answer

Probiotics only

us-abim MCQ (SBA): CDI Therapy Choice